Abstract:Microbiota profiles differ between patients with pancreatic cancer and healthy people, and understanding these differences may help in early detection of pancreatic cancer. Saliva sampling is an easy and cost-effective way to determine microbiota profiles compared to fecal and tissue sample collection.To investigate the saliva microbiome distribution in patients with pancreatic adenocarcinoma (PDAC) and the role of oral microbiota profiles in detection and risk prediction of pancreatic cancer.We conducted a prospective study of patients with pancreatic cancer ( = 41) and healthy individuals ( = 69). Bacterial taxa were identified by 16S ribosomal ribonucleic acid gene sequencing, and a linear discriminant analysis effect size algorithm was used to identify differences in taxa. Operational taxonomic unit values of all selected taxa were converted into a normalized Z-score, and logistic regressions were used to calculate risk prediction of pancreatic cancer.Compared with the healthy control group, carriage of and (z-score) was associated with a higher risk of PDAC [odds ratio (OR) = 5.344, 95% confidence interval (CI): 1.282-22.282, = 0.021 and OR = 6.886, 95%CI: 1.423-33.337, = 0.016, respectively]. and (z-score) were considered a protective microbe that decreased the risk of PDAC (OR = 0.187, 95%CI: 0.055-0.631, = 0.007 and OR = 0.309, 95%CI: 0.100-0.952, = 0.041, respectively). Among the patients with PDAC, patients reporting bloating have a higher abundance of ( = 0.039), ( = 0.024), and ( = 0.041); while patients reporting jaundice had a higher amount of ( = 0.008); patients reporting dark brown urine had a higher amount of ( = 0.035). Patients reporting diarrhea had a lower amount of and ( = 0.024 and = 0.034), and patients reporting vomiting had decreased ( = 0.036).Saliva microbiome was able to distinguish patients with pancreatic cancer and healthy individuals. may be specific for patients living in Sichuan Province, southwest China. Symptomatic patients had different bacteria profiles than asymptomatic patients. Combined symptom and microbiome evaluation may help in the early detection of pancreatic cancer.

Does Oral Microbiota Have a Close Relationship with Pancreatic Cancer? A Systematic Review and Meta-Analysis

Microbiota Regulates Pancreatic Cancer Carcinogenesis through Altered Immune Response.

Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review)

Microbial alterations of oral cavity and their association with Pancreatic Cancer

Oral Health and the Oral Microbiome in Pancreatic Cancer: An Overview of Epidemiological Studies

Associations Between Poor Oral Hygiene and Risk of Pancreatic Cancer

Oral microbiome and its relationship with oral cancer

Prognostic impact of oral microbiome on survival of malignancies: a systematic review and meta-analysis

Association of the Microbiota and Pancreatic Cancer: Opportunities and Limitations

The role of oral microbiota in cancer

The Oral-Gut Microbiome Axis in Breast Cancer: from Basic Research to Therapeutic Applications

Gut microbiome changes associated with chronic pancreatitis and pancreatic cancer: a systematic review and meta-analysis

Oral Microbiota as Promising Diagnostic Biomarkers for Gastrointestinal Cancer: A Systematic Review

Oral microbiome and pancreatic cancer

The Unique Microbiome and Immunity in Pancreatic Cancer

Current status and prospect of gut and oral microbiome in pancreatic cancer: Clinical and translational perspectives

Gut Microbial Profile in Patients with Pancreatic Cancer

Relationship between oral microbiota and colorectal cancer: A systematic review

Microbiome and pancreatic cancer: A comprehensive topic review of literature

Microbiomes in pancreatic cancer can be an accomplice or a weapon

Comparisons of oral, intestinal, and pancreatic bacterial microbiomes in patients with pancreatic cancer and other gastrointestinal diseases